Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page
- ChecktodayChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the page. The update does not modify the study details or displayed data.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision updated from v3.5.2 to v3.5.3, indicating a newer version of the page documentation. No substantive study content appears to be altered.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAlbert Einstein College of Medicine was removed from the Collaborators and Investigators section; the record shows updates including Revision: v3.5.2 and new entries dated 2026-04-07 and 2026-04-09.SummaryDifference0.6%

- Check58 days agoChange DetectedPage metadata updated to Revision: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded new collaborators/institutions (Henry Ford Cancer Institute, New York University, University of Michigan) and Merck Sharp & Dohme LLC to the study record. Included a link to the SPRINT publication in The Journal of Clinical Oncology and introduced a Study Results section with revision v3.4.3.SummaryDifference0.7%

- Check93 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government funding/operating status notice (v3.4.1). These changes are site-wide maintenance updates and do not affect the study details on the page.SummaryDifference0.4%

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.